Cargando…
Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
Dendritic cell (DC) immunotherapy is capable of generating tumour-specific immune responses. Different maturation strategies were previously tested to obtain DC capable of anti-cancer responses in vitro, usually with limited clinical benefit. Mutual comparison of currently used maturation strategies...
Autores principales: | Vopenkova, Katerina, Mollova, Klara, Buresova, Ivana, Michalek, Jaroslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118250/ https://www.ncbi.nlm.nih.gov/pubmed/22882679 http://dx.doi.org/10.1111/j.1582-4934.2012.01614.x |
Ejemplares similares
-
Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment
por: Hopewell, Emily L., et al.
Publicado: (2020) -
Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011) -
Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
por: Shinde, Prajakta, et al.
Publicado: (2018) -
Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells
por: Azeem, Waqas, et al.
Publicado: (2021) -
Follicular dendritic-like cells derived from human monocytes
por: Heinemann, Dagmar EH, et al.
Publicado: (2005)